Your browser doesn't support javascript.
loading
Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis.
Kiefer, David; Schneider, Lucia; Braun, Juergen; Kiltz, Uta; Kolle, Niklas; Andreica, Ioana; Tsiami, Styliani; Buehring, Bjoern; Sewerin, Philipp; Herbold, Susanne; Baraliakos, Xenofon.
Afiliación
  • Kiefer D; Ruhr-University Bochum, Bochum, Rheumazentrum Ruhrgebiet, Claudiusstrasse 45, Herne 44649, Germany.
  • Schneider L; Ruhr-Universität Bochum, Herne, Rheumazentrum Ruhrgebiet, Germany.
  • Braun J; Ruhr-Universität Bochum, Herne, Rheumazentrum Ruhrgebiet, Germany.
  • Kiltz U; Ruhr-Universität Bochum, Herne, Rheumazentrum Ruhrgebiet, Germany.
  • Kolle N; Ruhr-Universität Bochum, Herne, Rheumazentrum Ruhrgebiet, Germany.
  • Andreica I; Ruhr-Universität Bochum, Herne, Rheumazentrum Ruhrgebiet, Germany.
  • Tsiami S; Ruhr-Universität Bochum, Herne, Rheumazentrum Ruhrgebiet, Germany.
  • Buehring B; Bergisches Rheuma-Zentrum Wuppertal, Ruhr-Universität Bochum, Herne, Nordrhein-Westfalen, Germany.
  • Sewerin P; Rheumazentrum Ruhrgebiet, Ruhr-Universität Bochum, Herne, Germany Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Germany.
  • Herbold S; Ruhr-Universität Bochum, Herne, Rheumazentrum Ruhrgebiet, Germany.
  • Baraliakos X; Ruhr-Universität Bochum, Herne, Rheumazentrum Ruhrgebiet, Germany.
Ther Adv Musculoskelet Dis ; 16: 1759720X231224212, 2024.
Article en En | MEDLINE | ID: mdl-38404654
ABSTRACT

Background:

Patients with axial spondyloarthritis (axSpA) are often compromised by impaired function and mobility. The standardized 2-week inpatient program 'multimodal rheumatologic complex treatment' (MRCT) was designed for patients with axSpA. The Epionics SPINE (ES) is an objective tool validated to assess mobility.

Objective:

To investigate the impact of MRCT on physical function and mobility including range of motion (RoM) and kinematics (RoK).

Design:

Single-center interventional, observational trial.

Methods:

Patients with axSpA presenting with high disease activity and impaired physical function were consecutively recruited to undergo MRCT. Assessments performed before (V1) and after (V2) the intervention included Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis functional index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), the ankylosing spondylitis physical performance index (ASPI), the Short Physical Performance Battery (SPPB), and ES measurements.

Results:

At baseline, the 80 patients included had BASDAI 5.5 ± 1.5, BASFI 5.6 ± 2.0, BASMI 4.2 ± 1.8, SPPB 13.8 ± 1.8, and ASPI 37.3 ± 18.1 s. Clinically relevant improvements between V1 versus V2 were noted for BASFI, BASMI, and all other assessments (p < 0.001), and also for ES measures of RoK (all p < 0.003) and RoM (all p < 0.04), while a positive trend was seen for flexion and extension (RoM). There was no significant effect of changes in medication (all p > 0.05).

Conclusion:

The 2-weeks MRCT was associated with definite improvements of function and mobility. Importantly, the effect of this extensive physical activity was confirmed by using the ES as an objective tool to assess spinal mobility. The ES demonstrated for the first time that the RoK of spinal mobility can significantly improve related to an exercise intervention. Trial registration Ethical Committee Ruhr-Universität (reference-number 19-6735-BR).
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ther Adv Musculoskelet Dis Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ther Adv Musculoskelet Dis Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido